In Vitro and In Vivo Antimicrobial Activity of the Novel Peptide OMN6 against Multidrug-Resistant Acinetobacter baumannii

The rapid worldwide spread of antimicrobial resistance highlights the significant need for the development of innovative treatments to fight multidrug-resistant bacteria. This study describes the potent antimicrobial activity of the novel peptide OMN6 against a wide array of drug-resistant Acinetoba...

Full description

Saved in:
Bibliographic Details
Published inAntibiotics (Basel) Vol. 11; no. 9; p. 1201
Main Authors Michaeli, Janna, Mandel, Shira, Maximov, Shelly, Zazoun, Jonathan, Savoia, Paola, Kothari, Nimmi, Valmont, Thomas, Ferrari, Livia, Duncan, Leonard R., Hawser, Stephen, Cohen-Kutner, Moshe, Bachnoff, Niv
Format Journal Article
LanguageEnglish
Published Basel MDPI AG 05.09.2022
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The rapid worldwide spread of antimicrobial resistance highlights the significant need for the development of innovative treatments to fight multidrug-resistant bacteria. This study describes the potent antimicrobial activity of the novel peptide OMN6 against a wide array of drug-resistant Acinetobacter baumannii clinical isolates. OMN6 prevented the growth of all tested isolates, regardless of any pre-existing resistance mechanisms. Moreover, in vitro serial-passaging studies demonstrated that no resistance developed against OMN6. Importantly, OMN6 was highly efficacious in treating animal models of lung and blood infections caused by multidrug-resistant A. baumannii. Taken together, these results point to OMN6 as a novel antimicrobial agent with the potential to treat life-threatening infections caused by multidrug-resistant A. baumannii avoiding resistance.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2079-6382
2079-6382
DOI:10.3390/antibiotics11091201